Rare diseases
Investigational molecules
Locations
Back to Czechia207 clinical trials in Novy Hradec Kralove, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
CzechiaStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
CzechiaStudy on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis
CzechiaStudy Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
CzechiaStudy on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage
CzechiaStudy Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
CzechiaStudy on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment
CzechiaStudy Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy
CzechiaStudy of Tumor Treating Fields with Atezolizumab, Gemcitabine, and Nab-Paclitaxel for Patients with Metastatic Pancreatic Cancer
CzechiaStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on multiple sclerosis and Alzheimer's disease, evaluating novel therapeutic approaches including comparative studies of treatments like frexalimab and investigations of cognitive performance in early-stage Alzheimer's patients with inflammation markers.
Studies aim to assess treatment efficacy and disease progression markers.
Comprehensive research into blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and various lymphomas, testing innovative combination therapies and treatment approaches.
Focus on improving survival rates and treatment outcomes for blood cancer patients.
Studies examining treatments for chronic rhinosinusitis and uncontrolled asthma, with trials evaluating new medications like brensocatib and AZD8630 for symptom management and disease control.
Research focused on improving quality of life for patients with chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
